The National Heart, Lung, and Blood Institute (NHLBI) has an established record of encouraging and supporting the development of innovative genetic approaches to study monogenic disorders, including cystic fibrosis, familial hypertrophic cardiomyopathy, hemophilia, and sickle cell disease. While continuing its commitment to stimulate and support such efforts, the institute is placing a major emphasis on the use of existing knowledge to devise effective methods of genetic therapy for these diseases. One manifestation of that emphasis is the Working Group on Gene Therapy Approaches and Resources for Heart, Lung, and Blood Diseases, convened by the institute in 1992. Its charge was to identify new opportunities and chart a course for future research efforts.
The working group recognized that several clinical protocols involving gene transfer were already approved and generating data, but they noted the existence of barriers to the further evolution of human gene therapy. Although genetic interventions for heart, lung, and blood diseases may differ in the specifics of the approach, the working group identified common themes in scientific issues and resources fundamental to facilitating development of gene therapy for these diseases. Two The institute also recognizes that many gaps presently exist in our understanding of the more prevalent multifactorial disorders, such as hypertension and asthma, that impose a substantial economic and social burden. These diseases of complex inheritance and phenotype represent a new frontier because they do not follow the classic laws of genetics and because they involve special challenges that make progress difficult. Nonetheless, the remarkable scientific advances of recent years suggest that molecular genetics offers a timely approach that can realistically be expected to pay off within the foreseeable future.
To identify scientific priorities related to the genetic factors involved in the pathogenesis of cardiovascular, pulmonary, and hematologic diseases, the NHLBI convened an Expert Panel on Genetic Strategies for Heart, Lung, and Blood Diseases in 1992. The report of the expert panel provides a master plan that describes major research opportunities and operational strategies for their implementation. It reflects the collective judgment of an eminent group of researchers and critical, independent review by other scientists in the community. Successful implementation of this plan relies on a wide range of scientific disciplines, including genetics, biostatistics, epidemiology, molecular biology, genomics, physiology, clinical medicine, and biochemistry. It is a balanced approach that offers the brightest prospect for the future.
The NHLBI and its advisory council are planning new research initiatives based on the expert panel's report. An institute-wide program, The Mammalian Genotyping Service, is a shared support facility that will enable efficient, rapid genotyping for projects that use genetic linkage analyses, association studies, and mutational analyses to identify genetic determinants of disease. Two other new programs will establish networks that focus on the role of specific genetic mec ianisms in the development of disease. Since 1988, the institute has regularly reviewed all training grant applications to assess the adequacy of plans for recruitment of minority trainees. Unfortunately, in some cases we have had to defer applications from further consideration because such plans were unsatisfactory. Over the years, we have provided a number of resources to assist the community in achieving recruitment plan goals. To expand these resources and identify additional opportunities, the institute recently convened a Working Group on Recruitment of Minorities into NHLBI Training Grants. The working group is developing more effective strategies to improve recruitment of minorities into predoctoral and postdoctoral positions supported by our training grants. Its report will be shared with NHLBIsupported training directors and with others upon request.
The institute focuses considerable effort on attracting young people to careers in biomedical research through activities that provide minority students with individual research experiences. One such effort is the NHLBI Minority Access to Research Careers (MARC) Summer Research Training Program. It allows undergraduate students the opportunity to work in the laboratories of intramural NHLBI researchers. Since 1989, the institute has supported a total of 32 participants, most of whom subsequently entered graduate programs in biomedicine. The NHLBI also provides opportunities for similar research experiences in academic institutions.
It should be clear that the success of our efforts with respect to minority investigators hinges on the participation of the entire research community, minority and nonminority. The diversity of the American population is a strength that we must rely on as we prepare for the future.
